These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2424997)

  • 21. Characteristics of two anti-tumour monoclonal antibody preparations.
    Price MR; Dennick RG; Fang CY; Hannant D; Embleton MJ; Gunn B; Baldwin RW
    Arch Geschwulstforsch; 1981; 51(4):302-9. PubMed ID: 6947720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multisite monoclonal immunoassay for dengue viruses: detection of viraemic human sera and interference by heterologous antibody.
    Monath TP; Wands JR; Hill LJ; Gentry MK; Gubler DJ
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():639-50. PubMed ID: 2420923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble tumour-specific antigen and its relationship to tumour growth.
    Thomson DM
    Int J Cancer; 1975 Jun; 15(6):1016-29. PubMed ID: 50290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
    Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
    Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunofluorescent studies of cultured canine tumor cells.
    Bowles CA; Hagen W; Ditmore J; Kerber WT; Woods WA; Jensen EM
    Int J Cancer; 1972 Jul; 10(1):28-35. PubMed ID: 4122457
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
    Bruland O; Fodstad O; Skretting A; Pihl A
    Br J Cancer; 1987 Jul; 56(1):21-5. PubMed ID: 3476143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
    Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
    Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of immunological enhancement.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
    Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
    [No Abstract]   [Full Text] [Related]  

  • 29. Preparation of four daunomycin-monoclonal antibody 791T/36 conjugates with anti-tumour activity.
    Gallego J; Price MR; Baldwin RW
    Int J Cancer; 1984 Jun; 33(6):737-44. PubMed ID: 6376376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a cell-based fluorescent method for measuring antibody affinity.
    Yu X; Pegram CN; Bigner DD; Chandramohan V
    J Immunol Methods; 2017 Mar; 442():49-53. PubMed ID: 28024998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of target antigen density on the efficacy of immunomagnetic cell separation.
    Gee AP; Mansour VH; Weiler MB
    J Immunol Methods; 1991 Aug; 142(1):127-36. PubMed ID: 1717593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological responsiveness in rats infected with the Soehner-Dmochowski murine sarcoma virus (MSV-SD).
    Evans DL; Barnett JW; Dmochowski L
    Tex Rep Biol Med; 1974; 32(2):449-60. PubMed ID: 4372740
    [No Abstract]   [Full Text] [Related]  

  • 33. Uptake, penetration, and binding of monoclonal antibodies with increasing affinity in human osteosarcoma multicell spheroids.
    Hjelstuen MH; Rasch-Halvorsen K; Bruland O; De L Davies C
    Anticancer Res; 1998; 18(5A):3153-61. PubMed ID: 9858878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
    Affleck K; Embleton MJ
    Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 36. Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro.
    Dean CJ; Hobbs SM; Hopkins JU; North SM; Styles JM
    Br J Cancer; 1982 Aug; 46(2):190-7. PubMed ID: 7150472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.
    Pimm MV; Embleton MJ; Perkins AC; Price MR; Robins RA; Robinson GR; Baldwin RW
    Int J Cancer; 1982 Jul; 30(1):75-85. PubMed ID: 6956558
    [No Abstract]   [Full Text] [Related]  

  • 38. Dynamic quantification of antigen molecules with flow cytometry.
    Moskalensky AE; Chernyshev AV; Yurkin MA; Nekrasov VM; Polshchitsin AA; Parks DR; Moore WA; Filatenkov A; Maltsev VP; Orlova DY
    J Immunol Methods; 2015 Dec; 427():139-47. PubMed ID: 27030828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies.
    Sommarin Y; Rasmussen N; Wieslander J
    Exp Nephrol; 1995; 3(4):249-56. PubMed ID: 8590038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.
    Kure S; Yoshie O
    J Immunol; 1986 Dec; 137(12):3900-8. PubMed ID: 2431047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.